The PE Ratio as of July 2024 (TTM) for Inozyme Pharma, Inc. (INZY) is -4.32

According to Inozyme Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.32. This represents a change of 11.63% compared to the average of -3.87 of the last 4 quarters.

Inozyme Pharma, Inc. (INZY) Historical PE Ratio (quarterly & annually)

How has INZY PE Ratio performed in the past?

The mean historical PE Ratio of Inozyme Pharma, Inc. over the last ten years is -9.66. The current -4.32 PE Ratio has changed 4.37% with respect to the historical average. Over the past ten years (40 quarters), INZY's PE Ratio was at its highest in in the December 2022 quarter at -0.60. The PE Ratio was at its lowest in in the September 2019 quarter at -16.47.

Inozyme Pharma, Inc. (INZY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Inozyme Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Inozyme Pharma, Inc. (INZY) Average PE Ratio

How has INZY PE Ratio performed in the past?

The current PE Ratio of Inozyme Pharma, Inc. (INZY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Inozyme Pharma, Inc. (INZY) PE Ratio vs. Peers

How is INZY’s PE Ratio compared to its peers?

Inozyme Pharma, Inc.’s PE Ratio is greater than Day One Biopharmaceuticals, Inc. (-6.65), less than X4 Pharmaceuticals, Inc. (-1.34), less than Acumen Pharmaceuticals, Inc. (-3.72), greater than Mereo BioPharma Group plc (-82.75), greater than Terns Pharmaceuticals, Inc. (-7.36), less than PDS Biotechnology Corporation (-3.08), greater than HOOKIPA Pharma Inc. (-16.23), less than Eledon Pharmaceuticals, Inc. (-2.22), less than Amylyx Pharmaceuticals, Inc. (-1.88),

Build a custom stock screener for Inozyme Pharma, Inc. (INZY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inozyme Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inozyme Pharma, Inc. (INZY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inozyme Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.